These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15451157)

  • 21. Conservative approach to severe ulcerative colitis.
    Fedorak RN
    Dig Liver Dis; 2004 Jan; 36(1):4-6. PubMed ID: 14971809
    [No Abstract]   [Full Text] [Related]  

  • 22. Inflammation and atrial fibrillation: is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation?
    Tang RB; Dong JZ; Liu XP; Ma CS
    Med Hypotheses; 2006; 67(3):462-6. PubMed ID: 16793213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.
    Bertoli AM; Font YM; Nadal A; Vilá LM
    Arthritis Rheum; 2007 May; 56(5):1723; author reply 1723-4. PubMed ID: 17469171
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion.
    Korantzopoulos P; Kalantzi K; Siogas K; Goudevenos JA
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1272-6. PubMed ID: 18811807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.
    Aguiar-Souto P; Toquero-Ramos J; Fernández-Lozano I
    Pacing Clin Electrophysiol; 2006 Dec; 29(12):1452. PubMed ID: 17201859
    [No Abstract]   [Full Text] [Related]  

  • 26. Corticosteroids and atrial fibrillation: Risks or benefits?
    Liu T; Li G
    Arch Intern Med; 2006 Sep; 166(16):1785-6. PubMed ID: 16983061
    [No Abstract]   [Full Text] [Related]  

  • 27. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
    Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
    Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial.
    Prasongsukarn K; Abel JG; Jamieson WR; Cheung A; Russell JA; Walley KR; Lichtenstein SV
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):93-8. PubMed ID: 15999046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs.
    Shiroshita-Takeshita A; Brundel BJ; Lavoie J; Nattel S
    Cardiovasc Res; 2006 Mar; 69(4):865-75. PubMed ID: 16405878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of C-reactive protein levels in patients who do and do not develop atrial fibrillation during electrophysiologic study.
    Pirat B; Atar I; Ertan C; Bozbas H; Gulmez O; Müderrisoglu H; Ozin B
    Am J Cardiol; 2007 Nov; 100(10):1552-5. PubMed ID: 17996518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can perioperative C-reactive protein and interleukin-6 levels predict atrial fibrillation after coronary artery bypass surgery?
    Ziabakhsh-Tabari S
    Saudi Med J; 2008 Oct; 29(10):1429-31. PubMed ID: 18946567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study.
    Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
    Fujiki A; Sakamoto T; Nishida K; Mizumaki K; Inoue H
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):264-6. PubMed ID: 17878753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization.
    Lo B; Fijnheer R; Nierich AP; Bruins P; Kalkman CJ
    Ann Thorac Surg; 2005 May; 79(5):1530-5. PubMed ID: 15854929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation.
    Liu T; Li L; Korantzopoulos P; Goudevenos JA; Li G
    Am J Cardiol; 2008 Jun; 101(12):1749-52. PubMed ID: 18549852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
    Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
    Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome.
    Rizos I; Tsiodras S; Rigopoulos AG; Dragomanovits S; Kalogeropoulos AS; Papathanasiou S; Sakadakis EA; Kremastinos DT
    Cytokine; 2007 Dec; 40(3):157-64. PubMed ID: 17923414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory action of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Mascitelli L; Pezzetta F
    J Am Coll Cardiol; 2006 Feb; 47(4):889; author reply 890-1. PubMed ID: 16487865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.